Charney DS - Search Results

1

Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.

Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Grunebaum M, Oquendo MA, Kadriu B, Akula N, Henter I, Yuan P, Merikangas K, Drevets W, Furey M, Mann JJ, McMahon FJ, Zarate CA Jr, Shugart YY. Guo W, et al. Among authors: charney ds. Transl Psychiatry. 2019 Mar 5;9(1):108. doi: 10.1038/s41398-019-0442-5. Transl Psychiatry. 2019. PMID: 30837454 Free PMC article.

2

The cellular neurobiology of depression.

Manji HK, Drevets WC, Charney DS. Manji HK, et al. Among authors: charney ds. Nat Med. 2001 May;7(5):541-7. doi: 10.1038/87865. Nat Med. 2001. PMID: 11329053 Review.

3

New insights into the role of cortisol and the glucocorticoid receptor in severe depression.

Gold PW, Drevets WC, Charney DS. Gold PW, et al. Among authors: charney ds. Biol Psychiatry. 2002 Sep 1;52(5):381-5. doi: 10.1016/s0006-3223(02)01480-4. Biol Psychiatry. 2002. PMID: 12242053 No abstract available.

4

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA Jr, Charney DS. Manji HK, et al. Among authors: charney ds. Biol Psychiatry. 2003 Apr 15;53(8):707-42. doi: 10.1016/s0006-3223(03)00117-3. Biol Psychiatry. 2003. PMID: 12706957 Review.

5

Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.

Zarate CA Jr, Du J, Quiroz J, Gray NA, Denicoff KD, Singh J, Charney DS, Manji HK. Zarate CA Jr, et al. Among authors: charney ds. Ann N Y Acad Sci. 2003 Nov;1003:273-91. doi: 10.1196/annals.1300.017. Ann N Y Acad Sci. 2003. PMID: 14684452 Review.

6

An open-label trial of riluzole in patients with treatment-resistant major depression.

Zarate CA Jr, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, Charney DS, Manji HK. Zarate CA Jr, et al. Among authors: charney ds. Am J Psychiatry. 2004 Jan;161(1):171-4. doi: 10.1176/appi.ajp.161.1.171. Am J Psychiatry. 2004. PMID: 14702270 Clinical Trial.

7

Discovering endophenotypes for major depression.

Hasler G, Drevets WC, Manji HK, Charney DS. Hasler G, et al. Among authors: charney ds. Neuropsychopharmacology. 2004 Oct;29(10):1765-81. doi: 10.1038/sj.npp.1300506. Neuropsychopharmacology. 2004. PMID: 15213704 Review.

8

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Zarate CA Jr, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK. Zarate CA Jr, et al. Among authors: charney ds. Biol Psychiatry. 2004 Jul 1;56(1):54-60. doi: 10.1016/j.biopsych.2004.03.013. Biol Psychiatry. 2004. PMID: 15219473 Clinical Trial.

9

Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC. Neumeister A, et al. Among authors: charney ds. Arch Gen Psychiatry. 2004 Aug;61(8):765-73. doi: 10.1001/archpsyc.61.8.765. Arch Gen Psychiatry. 2004. PMID: 15289275 Clinical Trial.

10

No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder.

Bonne O, Bain E, Neumeister A, Nugent AC, Vythilingam M, Carson RE, Luckenbaugh DA, Eckelman W, Herscovitch P, Drevets WC, Charney DS. Bonne O, et al. Among authors: charney ds. Am J Psychiatry. 2005 Feb;162(2):383-5. doi: 10.1176/appi.ajp.162.2.383. Am J Psychiatry. 2005. PMID: 15677606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

631 results

Search Page